Glycopyrrolate Injection
Product Images NDC 16729-473

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 16729-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Glycopyrrolate Structural Formula (Glycopyrrolate Injection 1)

Glycopyrrolate Structural Formula (Glycopyrrolate Injection 1)
FDA Label Image

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 10 X 20 mL Multiple Dose Vials (Glycopyrrolate Injection 10)

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 10 X 20 mL Multiple Dose Vials (Glycopyrrolate Injection 10)
This is a medication called Glycopyrrolate Injection, USP used for intravenous or intramuscular administration. It comes in a 20mL multiple dose vial and is not for use in newborns. It contains Benzyl Alcohol and is usually dosed according to the package insert. It is manufactured by Accord Healthare, Inc. in Durham, USA and Intas Pharmaceuticals Limited, in Ahmedabad, India. The medication should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 16°-30°C (59°-86°F). Lot and EXP numbers are located on a 2D matrix 23X 25mm.*
FDA Label Image

Glycopyrrolate Injection 11

Glycopyrrolate Injection 11
Glycopyrrolate Injection, USP is available in 0.2 mg/mL strength with 10x20 mL multiple-dose vials. It is used for intravenous administration for overcoding. The medication is free from harmful substances and can be used for patients with necessary hydronorc acid and sodium iodide. The usual dosage can be obtained from the package. The injection is manufactured by Pramacmgss Led and includes benzyl alcohol. The product will remain stable at room temperature.*
FDA Label Image

Glycopyrrolate Injection, Usp 0.2 mg/ml 1 mL Single Dose Vial (Glycopyrrolate Injection 2)

Glycopyrrolate Injection, Usp 0.2 mg/ml 1 mL Single Dose Vial (Glycopyrrolate Injection 2)
This is a description of Glycopyrrolate Injection, USP, a medication that comes in a single dose vial with benzyl alcohol for intramuscular or intravenous administration. The manufacturer is Accord Health care, Inc. The dosage information is available in the package insert. The text also provides identification and manufacturing numbers.*
FDA Label Image

Glycopyrrolate Injection, Usp 0.2 mg/ml 25 X 1 mL Single Dose Vials (Glycopyrrolate Injection 3)

Glycopyrrolate Injection, Usp 0.2 mg/ml 25 X 1 mL Single Dose Vials (Glycopyrrolate Injection 3)
This is a description of Glycopyrrolate Injection USP, with NDC 16729-471-63, and manufactured by Accord Healthcare. It is for intramuscular or intravenous administration and the usual dosage must be followed while keeping the area in mind. It is a single-dose vial containing 1 mL liquid and the package insert must be referred to for more information. It is also mentioned that it contains Benzyl Alcohol.*
FDA Label Image

Glycopyrrolate Injection, Usp 0.4 mg/2 mL (0.2 mg/ml) 2 mL Single Dose Vial (Glycopyrrolate Injection 4)

Glycopyrrolate Injection, Usp 0.4 mg/2 mL (0.2 mg/ml) 2 mL Single Dose Vial (Glycopyrrolate Injection 4)
This is a description of a medication called Glycopyrrolate injection, USP. It comes in 25 single dose vials, with each vial containing 1 mL of the medicine and is for intramuscular or intravenous administration. The dosage is to be determined by a healthcare professional and the medicine should be stored between 15-30°C. It is not recommended for use in newborns as it contains Benzyl Alcohol and the pH may need to be adjusted.*
FDA Label Image

Glycopyrrolate Injection, Usp 0.4 mg/2 mL (0.2 mg/ml) 25 X 2 mL Single Dose Vials (Glycopyrrolate Injection 5)

Glycopyrrolate Injection, Usp 0.4 mg/2 mL (0.2 mg/ml) 25 X 2 mL Single Dose Vials (Glycopyrrolate Injection 5)
Description: Glycopyrrolate Injection is a medication given through intravenous or intramuscular administration. It comes in a 2mL Single Dose Vial and contains 0.02mg of Glycopyrrolate per gram. The medication is available as per the USP standards. The text contains information on the dosage, packaging information, and some chemical characteristics.*
FDA Label Image

Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) 5 mL Multiple Dose Vial (Glycopyrrolate Injection 6)

Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) 5 mL Multiple Dose Vial (Glycopyrrolate Injection 6)
This is a description of Glycopyrrolate Injection, USP, which is for Intramuscular or Intravenous administration only. The package contains a 2mL single-dose vial, with a usual dosage that can be found inside. The product must be stored at 20°C to 25°C with excursions permitted between 15°C to 30°C. The manufacturer is Accord Healthcare, Inc. and it is manufactured in Durham, North Carolina. It is Rx only and contains Benzyl Alcohol. The text also contains details such as NDC, batch codes, and manufacturing licenses.*
FDA Label Image

Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) 10 X 5 mL Multiple Dose Vials (Glycopyrrolate Injection 7)

Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) 10 X 5 mL Multiple Dose Vials (Glycopyrrolate Injection 7)
This is a description of a medication - Glycopyrrolate injection, USP, available in 25 x 2 mL single dose vials. The package is labeled with NDC 16729-472-08 and is for Rx only. This medication contains Benzyl Alcohol and is not intended for use in newborns. It is for intramuscular or intravenous administration only. The dosage is to be decided by a healthcare professional. The medication should be stored between 15-30°C (50°-35°F) at USP controlled room temperature.*
FDA Label Image

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 20 mL Multiple Dose Vial-label (Glycopyrrolate Injection 8)

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 20 mL Multiple Dose Vial-label (Glycopyrrolate Injection 8)
The text appears to be a mix of medical terms, drug names, dosage instructions, and manufacturing details. The has made some errors, but it seems like the text is from the packaging or the documentation of a drug called "Glycopyrrolate Injection". The drug contains Benzyl Alcohol as a preservative and requires pH adjustment. The recommended dosage is not available in the given text. The drug should be stored at a temperature between 20°C to 25°C and is not suitable for use in newborns. The drug is manufactured by Accord Healthcare Inc. and Inas Pharmaceuticals Limited located in India.*
FDA Label Image

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 20 mL Multiple Dose Vial-mono Carton (Glycopyrrolate Injection 9)

Glycopyrrolate Injection, Usp 4 mg/20 mL (0.2 mg/ml) 20 mL Multiple Dose Vial-mono Carton (Glycopyrrolate Injection 9)
This seems to be a label of a medication named Glycopyrrolate. It is given through injection and is not recommended for newborns. The label includes information about dosage, storage, and NDC numbers. However, some of the text is not available or readable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.